MANY COUNTRIES DO NOT ALLOW US DRUG COMPANIES TO PASS ALONG DEVELOPMENT COSTS IN PRICING PATENTED DRUGS. AMERICAN CONSUMERS PICK UP THESE COSTS. WE SHOULD ENACT AN EXPORT TARIFF ON THESE DRUGS TO RECOVER PRO-RATED COSTS. THIS MONEY WOULD BE REBATED TO DRUG COMPANIES WITH PROOF THAT THEY HAVE LOWERED THEIR COST TO US CONSUMERS. AN EASY TO SWALLOW DRUG COST REDUCTION PROPOSAL.
